RecruitingNot ApplicableNCT07519980

Xanthigen and Its Impact on Weight and Metabolic Health

Effects of Xanthigen on Weight Control and Metabolic Variables in Overweight Individuals

Sponsor

Universidad Católica San Antonio de Murcia

Enrollment

180 participants

Start Date

Feb 2, 2026

Study Type

INTERVENTIONAL

Conditions

Obesity, Overweight

Summary

Randomized, controlled, triple-blind clinical trial with three parallel arms based on the product consumed (low-dose experimental product, high-dose experimental product, and placebo product) and conducted at a single center to measure the efficacy of a product (Xanthigen®) on overweight or obesity during 16 weeks of consumption.

Eligibility

Min Age: 20 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Control product and Experimental group: Xanthigen® for people with obesity, overweight. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.